Ionis analyst coverage
Web12 apr. 2024 · UBS Group assumed coverage on shares of Capital Southwest (NASDAQ:CSWC – Get Rating) in a research note released on Tuesday, The Fly reports. The firm issued a neutral rating and a $19.00 target ... Web1 apr. 2024 · Ionis’s Young Investigator Grant Program is named in honor of Dr. Janice Wiesman (1958-2024), a world expert on the neurological impact of amyloidosis who …
Ionis analyst coverage
Did you know?
Web11 feb. 2024 · CARLSBAD, Calif., Feb. 11, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the European Medicines Agency (EMA) has granted orphan drug designation to ION373 for the treatment of people with Alexander disease, a severe, progressive and debilitating … WebThe Ionis antisense pipeline Our antisense technology platform has served as a springboard for drug discovery and realized hope for patients with unmet needs. Our …
Web5 mrt. 2024 · C iti analyst Joel Beatty began coverage of the stock with a Buy rating.. Citi analyst Joel Beatty began coverage of the stock with a Buy rating. Ionis … Web11 apr. 2024 · Finally, StockNews.com assumed coverage on shares of Ionis Pharmaceuticals in a report on Thursday, March 16th. They issued a “hold” rating on the stock. Two analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock.
Web26 jul. 2024 · To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma. Ionis' Forward-looking Statement. This press release includes forward … Web20 mrt. 2024 · Ionis Pharmaceuticals Price Performance. Shares of NASDAQ:IONS opened at $35.18 on Thursday. The company has a debt-to-equity ratio of 2.06, a quick ratio of …
Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of $67.00 and a low of $27.00.
Web12 apr. 2024 · Finally, StockNews.com assumed coverage on Range Resources in a research report on Thursday, March 16th. They set a hold rating for the company. Two research analysts have rated the stock with... grant williams height in feetWeb23 rijen · Analyst Coverage Ionis Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Ionis Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do … chipotle roseburg orWeb6 apr. 2024 · According to analysts, Ionis Pharmaceuticals's stock has a predicted upside of 20.00% based on their 12-month price targets. What analysts cover Ionis … grant wilfley appWeb14 apr. 2024 · High-density OCT thickness analysis has shown that the central RPE–BrM complex is thicker in intermediate AMD than early AMD, likely due to the build-up of lipoprotein-related lipids . The thickness of the RPE–BrM complex, outer plexiform, and outer nuclear layers decreases with increasing eccentricity from the foveal centre, which … chipotle rolling road springfield vaWebAssociate & MarketBook Manager. DeciBio. Jan 2024 - Sep 20249 months. Los Angeles, California, United States. Established a unique dual role as an Associate for the consulting team and MarketBook ... grant williams investmentWeb29 mrt. 2024 · As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and … chipotle rolling hillsWeb12 apr. 2024 · According to analysts' consensus price target of $45.17, Ionis Pharmaceuticals has a forecasted upside of 22.8% from its current price of $36.79. … chipotle roosevelt blvd jacksonville fl